Analyst Conference Summaries

Biotechnology Investor Aids

Celldex Therapeutics
CLDX

Conference date: August 8, 2017 @ 1:30 PM Pacific Time

Celldex Set to Bounce Back [April 15, 2015 @ Seeking Alpha]

Juno Therapeutics: Celgene Partnership and CAR-T Pipeline Value [Sept. 9, 2015]

Celldex Q2 2015 Results [press release August 10, 2015]

Celldex did not hold a Q1 2016 analyst conference call. So I am providing a link to the press release.

2017
 
 
May 9, 2017
August 8, 2017
 
 
2016
05/05/2016
08/08/2016
11/07/2016
03/14/2017
2015

Celldex Q2
analyst call
not available  
08/10/2015
11/05/2015
02/25/2016

Celldex Therapeutics (CLDX) is a biotechnology company developing therapies for cancers.

Celldex Therapeutics web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 BIND
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 HNSN
 INO
 INTC
 ISRG
 JUNO
 MACK
 MCHP
 MDVN
 MYL.
 NVDA
 OPXA
 PLX
 REGN
 SGEN
 XLNX
 XLRN

 
 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. This is investment journalism, not financial advice.

Copyright 2015 William P. Meyers